EN DE

Ilyda SA (ILYDA) Fair Value & Analysis

Technology · GR · Market cap €61.1M

IS Ilyda SA ILYDA · AT
Price€4.10
Fair Value€6.28
Upside+53.2%
Quality54/100
Watch Ilyda SA for free, get notified when fair value or trend changes. Watch for free
Mixed Growth
Highly profitable · 49.2% net margin
Low debt
Ranks above peers (8/13)
Wide moat 89/100
Evidence: High Range €4.69 – €7.85 Share as image

Fair value as of: Jul 17, 2026

From 24 valuation models · updated 24 days ago

Share price −3.1% over the past month.

A solid business, screening 53% undervalued on our models.

What matters now

  • The price is below even our cautious bear case (€4.69). The market is more pessimistic than our downside scenario.
  • Solid quality (54/100) at a price below fair value, the discount is the argument here, not the business quality.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

€5.72 €0.5893 Fair Value €6.28 Apr 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 17, 2026.

How to read this chart

60‑month range €0.5893 – €5.72 · fair‑value band €4.69 – €7.85 · the €4.10 price screens below the €6.28 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 17, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Ilyda SA (ILYDA) currently trades at €4.10, while our model-based Fair Value estimate is €6.28, implying the stock looks roughly 53.2% undervalued today. The Quality Score stands at 54/100 (solid quality), in the Technology sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.

Over the trailing twelve months, Ilyda SA generated revenue of €9.0M at a net margin of 49.2%. Revenue grew 4.4% year over year. It earns a return on equity of 36.3%. The stock trades on a trailing P/E of 14.0. Fundamentals as of Jul 17, 2026

Our scenario range runs from €4.69 (bear case) to €7.85 (bull case); at €4.10, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 29% below its 52-week high and 60% above its 52-week low, currently below its 200-day average. For context, the median of 10 Technology peers we cover trades at -27% fair-value upside, at 53%, ILYDA screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Growth DCF €3.97 €5.95 €9.48 80
Rev-Margin DCF €2.61 €4.04 €6.70 74
ROIC Compounder €3.63 €4.52 €5.57 72
All 24 models by family
DCF Models
FCF DCF €4.21 €5.71 €10.09 38
Owner Earnings €1.25 €2.00 €3.32 31
5Y Revenue Exit €2.57 €3.58 €5.67 39
5Y EBITDA Exit €4.89 €8.27 €14.89 41
5Y P/E Exit €4.84 €10.07 €17.17 38
10Y Revenue Exit €3.13 €5.11 €6.02 36
10Y EBITDA Exit €4.62 €9.37 €17.56 37
10Y P/E Exit €4.59 €9.27 €16.89 35
Earnings-Based
Graham-Dodd €2.13 €14.88 €20.89 54
Lynch FV €5.91 €8.45 €10.98 50
PEG = 1.0 €5.91 €8.45 €10.98 46
EPV €3.18 €3.50 €3.77 59
Multiples
P/E Multiple €4.71 €6.28 €7.85 63
P/S Multiple €1.20 €1.59 €1.99 58
P/B Multiple €2.57 €3.43 €4.29 55
EV/EBIT €6.16 €8.06 €9.95 53
EV/EBITDA €5.26 €6.85 €8.45 54
EV/Revenue €1.58 €2.06 €2.54 43
Asset-Based
NCAV (Graham) €0.5700 €0.7700 €1.14 50
Growth DCF
Growth DCF €3.97 €5.95 €9.48 80
Rev-Margin DCF €2.61 €4.04 €6.70 74
Economic Profit
Residual Income €1.64 €2.23 €9.83 61
ROIC Compounder €3.63 €4.52 €5.57 72
Growth Earnings
Growth-Adj P/E €7.31 €10.45 €13.58 68

Widest divergence: Growth Earnings (€10.45) versus Asset-Based (€0.7700). Highest evidence: Growth DCF (80).

Notify me when ILYDA reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) €9.0M
Revenue growth (YoY) +4.4%
Net margin 49.2%
Return on equity 36.3%
P/E ratio 14.0
Operating margin 106%
More key figures
EPS (TTM) €0.3100
EPS growth (YoY) +33.4%

Figures from reported company fundamentals · as of Jul 17, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 54/100

Of which business quality 59 · Market factors (momentum, volatility) 45

Profitability 74
Margins and returns on capital today
Quality Growth 40
Are margins and returns improving?
Cashflow 75
Earnings quality: real cash, not paper profit
Fin. Strength 100
Balance sheet, leverage, solvency risk
Investment 0
Disciplined investing over empire-building
Low Volatility 50
Calm price path (market factor)
Momentum 39
Price trend over the last 3–12 months (market factor)
52W Momentum 52
Distance to the 52-week high (market factor)
Net Issuance 20
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Ilyda SA engages in software development business in Greece. It offers enterprise resource planning systems, such as MegaTron ERP and Kinitron Smart ERP; Dioscourides Smart, Dioscourides Touch XPress, and Dioscourides ERP Retail System for pharmacies; MegaTron Pharma ERP for drugstores; and LIS Bio-Diagnosis for microbiological laboratories.

Full company description

Ilyda SA engages in software development business in Greece. It offers enterprise resource planning systems, such as MegaTron ERP and Kinitron Smart ERP; Dioscourides Smart, Dioscourides Touch XPress, and Dioscourides ERP Retail System for pharmacies; MegaTron Pharma ERP for drugstores; and LIS Bio-Diagnosis for microbiological laboratories. The company also provides MegaTron DEVA for water supply/sewerage companies; PSIS Financial Management for public sector companies; PSIS Payroll & Personnel Management for legal entities; and SIS Secretariats of Educational Institutions for educational institutions. In addition, it provides software support services, such as telephone support, remote support, on-site support, and feedback support services; project design and implementation; software training services; and consultant agency services. The company was founded in 1992 and is headquartered in Athens, Greece.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2019 – FY2025 · reported fiscal years

Ilyda SA reported revenue of €9.0M in FY2025 versus €2.8M in FY2019, a compound +21.4%/yr. Reported net income was €4.4M in FY2025.

Growth Quality 86/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Latest Revenue (FY 2025)
€9.0M
Latest YoY
+26.4%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+27.4%
Avg. growth/yr (10Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+13.4%
Revenue +21.4%/yr
FY19 €2.8M
FY21 €4.4M
FY22 €4.4M
FY24 €7.1M
FY25 €9.0M
Net income
FY19 −€38.0K
FY21 €430K
FY22 €1.3M
FY24 €3.8M
FY25 €4.4M

Watch ILYDA: get an alert when its fair value changes →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Ilyda SA Fair Value". https://www.fairvalue-calculator.com/stock/ILYDA

Peer Group

Software - Application · 709 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 54 · Below median
Fair Value upside +53% · Top 25%
Return on equity (TTM) 36% · Top 25%
Return on assets 21% · Top 25%
Net margin (TTM) 49% · Top 25%
Operating margin (TTM) 106% · Top 25%
Revenue growth 4% · Below median
Dividend yield (TTM) 0.0% · Bottom 25%

Valuation Multiples vs Software - Application median · lower = cheaper

P/E (TTM) 14.0× · Cheaper than 75% of peers
P/B 4.38× · Pricier than 75% of peers
P/S (TTM) 7.85× · Pricier than 75% of peers
EV/EBITDA 9.3× · Cheaper than median

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 100 · sector 0
FUTURE 22 · sector 38
PAST 100 · sector 13
HEALTH 100 · sector 98
DIVIDEND 0 · sector 28

Insider activity: 25/100

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Software - Application stocks, each showing price versus our Fair Value estimate (as of Jul 17, 2026).

Stock Price Fair Value vs Fair Value
SAP SE SAPS C$12.69 C$16.26 +28%
Shopify Inc SHOP C$173.23 C$20.54 -88%
Uber Technologies, Inc UBER $72.67 $51.11 -30%
Salesforce, Inc CRM $170.77 $182.10 +7%
ServiceNow, Inc NOW $107.71 $33.12 -69%
Cadence Design Systems, Inc CDNS $384.17 $80.41 -79%
Snowflake Inc SNOW $271.87 $34.04 -87%
Adobe Inc ADBE $230.61 $379.48 +65%
Automatic Data Processing, Inc ADP $241.92 $177.51 -27%
Intuit Inc INTU $291.09 $258.69 -11%

Compare Ilyda SA with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Technology stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Ilyda SA (ILYDA) overvalued or undervalued?
As of Jul 17, 2026, our model estimates a fair value of €6.28 versus a price of €4.10, about +53% (undervalued).
What is the fair value of ILYDA?
Our model-based fair value for Ilyda SA is €6.28 (as of Jul 17, 2026), built from audited fundamentals. The current price is €4.10.
What is the quality score of ILYDA?
Ilyda SA has a Quality Score of 54/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Ilyda SA (ILYDA)?
Ilyda SA reported trailing-twelve-month revenue of about €9.0M (latest available figure, as of Jul 17, 2026).
What is the net profit margin of ILYDA?
The net profit margin of Ilyda SA is about 49.2%, meaning it keeps roughly 49.2% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Ilyda SA and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.